SC 13G/A | 2022-04-11 | FMR LLC | SpringWorks Therapeutics, Inc. | 6,046,209 | 12.3% | EDGAR |
SC 13G/A | 2022-02-15 | PERCEPTIVE ADVISORS LLC | SpringWorks Therapeutics, Inc. | 4,849,912 | 9.8% | EDGAR |
SC 13G/A | 2022-02-14 | PFIZER INC | SpringWorks Therapeutics, Inc. | 2,340,330 | 4.8% | EDGAR |
SC 13G | 2022-02-10 | VANGUARD GROUP INC | SpringWorks Therapeutics, Inc. | 2,862,312 | 5.8% | EDGAR |
SC 13G/A | 2022-02-09 | FMR LLC | SpringWorks Therapeutics, Inc. | 3,946,320 | 8.0% | EDGAR |
SC 13D/A | 2021-08-12 | BC SW, LP | SpringWorks Therapeutics, Inc. | 4,831,307 | 9.8% | EDGAR |
SC 13D/A | 2021-03-11 | BC SW, LP | SpringWorks Therapeutics, Inc. | 5,831,307 | 11.9% | EDGAR |
SC 13D/A | 2021-03-04 | ORBIMED ADVISORS LLC | SpringWorks Therapeutics, Inc. | 6,186,307 | 12.6% | EDGAR |
SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | SpringWorks Therapeutics, Inc. | 4,177,721 | 8.6% | EDGAR |
SC 13G/A | 2021-02-12 | PFIZER INC | SpringWorks Therapeutics, Inc. | 4,583,047 | 9.4% | EDGAR |
SC 13G/A | 2021-02-11 | BIOTECHNOLOGY VALUE FUND L P | SpringWorks Therapeutics, Inc. | 27 | - | EDGAR |
SC 13G | 2021-02-08 | FMR LLC | SpringWorks Therapeutics, Inc. | 3,378,020 | 6.9% | EDGAR |
SC 13D/A | 2020-10-15 | BC SW, LP | SpringWorks Therapeutics, Inc. | 7,281,307 | 15.0% | EDGAR |
SC 13D/A | 2020-10-14 | ORBIMED ADVISORS LLC | SpringWorks Therapeutics, Inc. | 7,406,307 | 15.5% | EDGAR |
SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | SpringWorks Therapeutics, Inc. | 1,523,711 | 3.5% | EDGAR |
SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | SpringWorks Therapeutics, Inc. | 3,297,522 | 7.7% | EDGAR |
SC 13G | 2020-02-14 | PFIZER INC | SpringWorks Therapeutics, Inc. | 4,593,847 | 10.7% | EDGAR |
SC 13G | 2019-09-26 | PERCEPTIVE ADVISORS LLC | SpringWorks Therapeutics, Inc. | 3,217,522 | 7.4% | EDGAR |
SC 13D | 2019-09-25 | ORBIMED ADVISORS LLC | SpringWorks Therapeutics, Inc. | 7,406,307 | 17.1% | EDGAR |
SC 13D | 2019-09-24 | BC SW, LP | SpringWorks Therapeutics, Inc. | 7,281,307 | 16.8% | EDGAR |